Answers are grounded in this paper and cite their sources.
This analysis compares execution time of Python versions in 11 critical tests, suggesting 3.11.14 for production.
Microbenchmark Performance Analysis: Python 3.15.0a3 vs 3.11.14 Mehmet Keçeci ORCID: https://orcid.org/0000-0001-9937-9839 Received: 01.23.2026 Abstract: A comprehensive microbenchmark analysis comparing Python 3.15.0a3 (alpha) and Python 3.11.14 (stable) has been conducted on Linux/Conda-Forge platform. Eight runs (4 full + 4 summary benchmarks) per version measured 11 critical tests encompassing function calls, loop arithmetic, list/dict operations, string manipulation, mathematics, comprehensions, generators, recursion, LRU cache, attribute access, and exception handling. Key finding: Function calls dominate 99.9% of total execution time with no meaningful difference between versions (Py3.15: 61.934s, Py3.11: 61.820s, ratio=1.002). Microbenchmark-wise, Py3.11.14 demonstrates 64% superiority (7/11 tests). Comprehensions (1.338x) and generators (1.340x) exhibit 25-34% Py3.11 advantage, while Py3.15 excels in loops (0.821x) and attribute access (0.972x) by 2-18%. Linear scale visualization clarifies differences: Py3.11 leads in critical Python constructs (comprehensions, generators), while Py3.15 shows gains in fundamental arithmetic and attribute access. Standard deviation ranges 0.1-1.0%, indicating high measurement repeatability (95% CI ±1.5%). Practical implications: Python 3.11.14 recommended for production due to stability + microbenchmark superiority. Py3.15 alpha suitable for R&D projects where function calls are non-dominant. Comprehension/generator optimizations anticipated in Py3.15 final release. This study highlights Python evolution's function call dominance (99.9%) and microbenchmarks' disconnect from real-world performance. Keywords: Python microbenchmark, performance analysis, Python 3.15, Python 3.11, function calls, comprehension, generator, execution time, statistical analysis, benchmark repeatability.
No takes yet. Share an insight, caveat, or question.
Mehmet Keçeci (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: